bst2288全球奢华游戏(China)官网

CH / EN
About Kingfriend
Kingfriend Overview

Nanjing Kingfriend integrates drug research and development, production and sales.

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (NKF), headquartered in Nanjing, China, is a leading global biopharmaceutical enterprise dedicated to building an integrated platform for internationalization of its high-end injectables and to serve domestic pharmaceutical manufacturers in expanding their business around the globe. With over a dozen of ANDAs approved in US each year, NKF has grown into one of the biggest suppliers of high-end injectables in the US. NKF is also one of the biggest suppliers of Heparin APIs and finished dosage forms, and is actively working with partners from over 60 countries for over 80 USFDA approved products.
  • 80+
  • 10+
  • 9+
  • 10+
  • 10+
Total ANDA approvals
New ANDA approvals obtained each year
FDA-compliant high-speed isolator production line
Annual declaration of products to FDA
Cumulative number of FDA inspection passed
The Global Industry Layout

We establish efficient, integrated and open project management systems for global pharmaceutical companies

  • Nanjing Headquarter

    R&D Center
    Development, production and commercial manufacturing of small molecule injectables
    Drug development and commercialization based on mRNA technology
    Treatment based on nucleic acid detection technology (mRNA)
    Bioinformatics determination of target molecules
    platform for mRNA in vitro synthesis and modification
    Drug delivery system development

  • Cheng Du

    R&D center
    Hydro-acupuncture and lyophilization product line
    Monoclonal antibody-based drugs (mAb)
    Early research and development of monoclonal antibody
    Commercial development monoclonal antibodies

  • Chicago, USA

    Global Clinical Research Center
    U.S. Marketing
Milestones

Over the past 30 years, we have been refreshing our goals and making positive progress.

2023
License-in 3 top selling Insulins
2022
57 ANDA approvals obtained in total
pipeline expansion at a rate of 10 new projects per year
2021
Establishment of Bio-innovative Business Department
Improved R&D capabilities and entered the field of biologics
2019
Acquisition of US pharmaceutical company Meitheal
Broadened the global market of preparations and completed the coverage of the industry chain
2016
Acquisition of Chengdu Jianjin Pharmaceutical
Full set of FDA-compliant GMP workshop
audited by the FDA
2014
Passed CFDA GMP inspection
Obtained three domestic approvals and started filling with ANDA
2011
Construction of Nanjing FDF plant started
The world’s top FDF plant
2004
Launch of enoxaparin, nadroparin and dalteparin preparation projects
Initiated the development and declaration of heparin-based APIs and preparations
2000
Establishment of Nanjing Kingfriend Biochemical Pharmaceutical Co, Ltd
Ventured into pharmaceutical export business
1991
Establishment of Nanjing Kingfriend Chemical Biopharmaceutical Factory
Rapid development in heparin industry
1987
Involvement in the field of heparin sodium
Pioneer in the heparin industry in China
2023
2022
2021
2019
2016
2014
2011
2004
2000
1991
1987
Enterprise Honors

Our employees, who are enterprising and innovative, have obtained a number of remarkable achievements.

  • License-in 3 top selling Insulins
    2023
    License-in 3 top selling Insulins
  • Enterprise Technology Center recognized by Jiangsu Province
    2022
    Enterprise Technology Center recognized by Jiangsu Province
  • Nanjing Municipal Key Leading Enterprise of Agricultural Industrialization
    2022
    Nanjing Municipal Key Leading Enterprise of Agricultural Industrialization
  • National-level High-tech Enterprise Certificate
    2018
    National-level High-tech Enterprise Certificate
  • Awarded the title of Nanjing Outstanding Private Enterprise and Entrepreneur
    2018
    Awarded the title of Nanjing Outstanding Private Enterprise and Entrepreneur
  • Private Technology Enterprise Certificate
    2017
    Private Technology Enterprise Certificate
  • Awarded the title of Nanjing Smart Factory
    2015
    Awarded the title of Nanjing Smart Factory
  • Enterprise Technology Center recognized by Jiangsu Province
    2014
    Enterprise Technology Center recognized by Jiangsu Province
  • Outstanding Company of Open Economy of Jiangsu Province
    2012
    Outstanding Company of Open Economy of Jiangsu Province
More honors
Stock price
13.250
-0.45
©2024 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd苏ICP备13012010号